Table 1 Characteristics of the Eyes within the vitreoretinal interface pathologies group
Lamellar macular hole | Full-thickness macular hole | Epiretinal membrane | Post-macular peeling | All eyes | |
|---|---|---|---|---|---|
N, eyes | 12 (38.7%) | 4 (12.9%) | 8 (25.8%) | 7 (22.6%) | 31 (100.0%) |
Clinical data | |||||
Visual acuity, LogMAR (Snellen equivalent) | 0.50 ± 0.54 (20/63) | 0.52 ± 0.30 (20/66) | 0.47 ± 0.63 (20/59) | 0.24 ± 0.19 (20/34) | 0.43 ± 0.48 (20/53) |
Phakic lens status | 3 (25.0%) | 0 (0%) | 1 (12.5%) | 0 (0%) | 4 (12.9%) |
Glaucoma | 3 (25.0%) | 1 (25.0%) | 3 (37.5%) | 3 (42.9%) | 10 (32.3%) |
Retinal tear | 0 (0%) | 0 (0%) | 0 (0%) | 3 (42.9%) | 3 (9.7%) |
Retinal detachment | 1 (8.3%) | 1 (25.0%) | 2 (25.0%) | 1 (14.3%) | 5 (16.1%) |
SD-OCT features | |||||
Macular PVDa | 8/10 (80.0%) | 1/1 (100.0%) | 6/6 (100%) | – | 15/17 (88.2%) |
ERM | 8 (66.7%) | 1 (25.0%) | 8 (100.0%) | 3 (42.9%) | 20 (64.5%) |
ELM disruptionb | 8 (66.7%) | – | 2 (25.0%) | 4 (57.1%) | 14/27 (51.9%) |
EZ disruptionb | 9 (75.0%) | – | 2 (25.0%) | 4 (57.1%) | 15/27 (55.6%) |
N, ETDRS quadrants | 4.6 ± 1.7 | 4.0 ± 2.7 | 2.6 ± 2.0 | 2.7 ± 2.4 | 3.6 ± 2.2 |